Clinical Trials Browser

penpulimab × Head & Neck × 1 year × Clear all

NCT05807880 2026-01-23

ALTER-HN005

Phase 2 Active not recruiting

Nasopharyngeal Neoplasms

NCT06943820 2025-06-03

AK129 Combination Therapy for Advanced Solid Tumors

Phase 1/2 Recruiting

Squamous Cell Carcinoma of Head and Neck

NCT04974398 2025-04-13

A Study of Penpulimab (AK105) in the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma

Phase 3 Active not recruiting

296 enrolled 1 FDA

Nasopharyngeal Carcinoma